Skip to main content
ES
v1.2
Log in
C

Concord Biotech

CONCORD BIOTECHNSE
₹1,339-14.30 (-1.06%)as of 2026-10-16
Market Cap
₹14,035Cr.
P/E Ratio
49.4
P/B Ratio
6.94
EPS (TTM)
₹27.11
Day Range
₹1,332 – ₹1,366.8
Div Yield
0.55%
ROCE
17.4%
ROE
12.6%
52W Low: ₹98752W High: ₹1,615
Themes:💊 Pharma & CDMO
Appears in 1 screen
🏦Cash-Rich / Low-Debt
100
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 7.0% a year over three years.
  • Debt is 0.00× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Concord_Biotech — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5/ 10Overall
3/ 10Valuation
7/ 10Quality
5/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 49.4P/E: 49.4 | P/B: 6.94
Growth
ModestSales CAGR — 3Y: 7% · 1Y: -6%
Profitability
ModerateROCE: 17.4% | ROE: 12.6%

Key Metrics

Valuation
PEG Ratio 49.40
Price / Sales 12.62x
Price / FCF 83.0x
Book Value ₹193
Margins & returns
Operating Margin 36%
Net Margin 25.4%
Return on Assets 12.6%

Frequently Asked Questions

MarketsPortfolioChart